The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications
Article in Heliyon (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Effect of secretory leucocyte protease inhibitor on early tendon-to-bone healing after anterior cruciate ligament reconstruction in a rat model
Article in Bone and Joint Research (July 2022)
SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis
Article in International Journal of Biological Sciences (January 2022)